UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.


Evolution of patient access services
UBC - August 29, 2016
Sometimes it’s hard to remember that many patients who once had no treatment options are now living healthier lives while managing their disease thanks to new therapies.  Patients with multiple sclerosis are a perfect example....
Hybrid Study for Pharmaceutical Value Messages
Erwin De Cock, Scientific Consultant and Kristy Hanson, Scientific Consultant - August 25, 2016
Real-world data on effectiveness, safety, and other outcomes are increasingly being demanded by multiple stakeholders. Data can be obtained using secondary data sources (electronic medical records, claims/administrative data, existing...
Connected patient care | UBC
UBC - August 19, 2016
Reimbursement challenges can cause lengthy delays in therapy initiation for patients taking complex specialty medications. UBC’s new suite of digital tools are breaking down barriers to access and improving speed to therapy for...
FDA guidance for rare diseases
Irene Pan, MSc, Senior Research Scientist - August 18, 2016
By definition, a rare disease affects less than 200,000 Americans.1 Currently, there exists an estimated 5000-8000 rare diseases affecting more than 25 million Americans.2 The lack of adequate understanding of the pathophysiology and...
Pharma Heroes charity | International Medical Corps | UBC
UBC - August 16, 2016
The Pharma Hero campaign seeks to celebrate the great work of our colleagues in the pharma and biotech industry. We also wanted to do a little good work of our own by making a charitable donation for each Pharma Hero nomination we...